LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for more than a half century.

The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe generalized anxiety disorder, with the benefits lasting as long as three months. The company plans to conduct follow-up studies to confirm the results and then apply for Food and Drug Administration approval.

The Trump administration asked the Supreme Court to quickly decide the legality of President Donald Trump’s broad tariff regime and overturn a lower court ruling that found he exceeded his authority.

The Justice Department in a filing late Wednesday urged the just

See Full Page